Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Use of Beta-blockers and Risk of New Onset Diabetes
The completed trial update investigates whether use of beta-blockers is associated with an increased risk of new-onset diabetes in patients …
-
FDA approval · 2012-04-27FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental application for ATACAND (candesartan cilexetil). This action updates the drug's labeling as p…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Improving Blood Pressure in Colorado [NA]
A Kaiser Permanente-sponsored hypertension trial in Colorado has completed, with no detailed results provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Using the Blood Pressure TRU in Clinical Settings: a Knowledge Translation Study
A completed clinical trial update evaluating the use of the Blood Pressure TRU tool in routine clinical settings to improve knowledge transl…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Renin Profiling in Selection of Initial Antihypertensive Drug [NA]
A completed clinical study assessing whether renin profiling can guide the selection of initial antihypertensive therapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-04-19Clinical Trial Update: The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus [NA]
A completed clinical trial assessing the effects of green tea or cocoa extracts on endothelial dysfunction in patients with diabetes mellitu…
-
FDA approval · 2012-04-16FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for aliskiren hemifumarate filed by Prasco Laboratories. This action updates the regulatory status o…
-
FDA approval · 2012-04-10FDA Approved: EDARBYCLOR — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for Edarbyclor, a fixed-dose combination of azilsartan medoxomil and chlorthalidone, developed b…
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Home Blood Pressure Monitoring Project [NA]
Kaiser Permanente-sponsored hypertension trial evaluating home blood pressure monitoring has completed. The update does not include trial re…
-
CLINICAL_TRIALS withdrawal · 2012-04-06Clinical Trial Update: Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab [NA]
A clinical trial comparing nebivolol to lisinopril for new-onset or bevacizumab-induced hypertension has been withdrawn.
-
FDA approval · 2012-04-03FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Fosun Pharma USA Inc.)
The FDA approved the original ANDA for labetalol hydrochloride (generic) by Fosun Pharma USA Inc., authorizing its marketing as a generic an…
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP) [Phase 4]
Phase 4 clinical trial update for candesartan investigating effectiveness in patients with hypertension and left ventricular hypertrophy; th…
-
FDA approval · 2012-03-30FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's irbesartan and hydrochlorothiazide as an original ANDA, providing a generic version of the combination therapy for hyper…
-
FDA approval · 2012-03-29FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for candesartan cilexetil and hydrochlorothiazide from ANI Pharmaceuticals, Inc. The approval co…
-
FDA approval · 2012-03-29FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) submitted by Almatica Pharma Inc.
-
FDA approval · 2012-03-29FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Zestril (lisinopril) submitted by Upsher-Smith Laboratories.
-
CLINICAL_TRIALS trial_result · 2012-03-29Clinical Trial Update: Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation
This completed clinical trial from Istanbul University evaluated cardiovascular and renal outcomes after reducing renal mass via living kidn…
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: The Effect of Amiloride and Spironolactone in Patients With Hypertension [Phase 4]
This Phase 4 clinical trial evaluated the effects of amiloride and spironolactone in patients with hypertension. The study status is complet…
-
FDA approval · 2012-03-27FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure [Phase 4]
A Phase 4 clinical trial examining the effects of carvedilol CR and atenolol on central blood pressure in hypertension.
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Intervention Study on Hypertension Management Combined With Health Promotion at Commune Level [NA]
This completed trial in Vietnam evaluated hypertension management combined with commune-level health promotion. It examined whether a struct…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Long-term of 10 Years Results of a Prospective Longitudinal Study
Update reporting 10-year results from a prospective longitudinal trial involving individuals with Type 2 Diabetes Mellitus and hypertension.
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation
A completed Japanese trial (J-TARGET) evaluating telmisartan for long-term antihypertensive effect; results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Watermelon Supplementation and Arterial Stiffness [Phase 1, Phase 2]
A clinical trial update on watermelon supplementation for reducing arterial stiffness in hypertension; the study completed Phase 1 and Phase…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Telmisartan and Amlodipine Versus Monocomponent Tablets [Phase 1]
Phase 1 trial comparing a telmisartan/amlodipine combination to each monocomponent tablet for hypertension; results were posted in 2012.